Pharmaceutical Technology is the only peer-reviewed publication serving the largest requested circulation of 38,600 BPA-audited subscribers (June 2010 BPA Statement). Here is the October editorial lineup to give you a heads up on the coverage in this issue and to assist you in your decision to advertise in Pharmaceutical Technology this month.

Ad close is September 1 and your ad materials will be due on September 15.

EDITORIAL PREVIEW
October 2011
Editorial Content Subject To Change

Special Report: New Applications for Disposables
Amy Ritter, Pharmaceutical Technology

PEER REVIEWED RESEARCH
Assessment of Large Sample Unit Dose Uniformity Tests through Limiting Discriminatory Thresholds
Yanhui Hu and David LeBlond, both at Abbott

Pharma Ingredients: APIs & Excipients Report
Patricia Van Arnum, Pharmaceutical Technology

Case Study: The PQRI Risk Management Series

Position Paper: Regulatory and Statistical Implications of the Matrixx Zicam Verdict
Cathy Burgess, Sean Simmons, and Lynn D. Torbeck, representing Alston and PharmStat. Torbeck is also a member of our Editorial Advisory Board.

Quality Considerations Related to the Phase of Development for MultiRegional Clinical Trial Supplies
Dennis Sandell, Terrence Tougas, Dennis O’Connor, and Steve Horhota, with the Consulting Lund Firm and Boehringer Ingelheim Pharmaceuticals

Applying Dry Powder Coatings to Pharmaceutical Powders using a Resonant Aacoustic Mixer for Improving Powder Flow and Bulk Density
Matthew P. Mullarney, Lauren E. Beach, Beth A. Langdon, and Mark A. Polizzi, at Pfizer, the New Jersey Institute of Technology, and Aprecia Pharmaceuticals